IRDVSNGNE• 28 Days (Normalized)
IRD vs NGNE (Opus Genetics Inc. vs Neurogene Inc.)
Showing Closing Date Range from Aug, 18 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
IRD Performance $5.86
+58.67%
Opus Genetics Inc.
Normalized Baseline0.00%
NGNE Performance $34.09
-4.43%
Neurogene Inc.
Normalized Baseline0.00%
Alpha Spread Margin IRD LEADS
+63.1%
IRD outperforming by 63.10%
IRDNGNE
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
IRD NGNE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | IRD Price | IRD Gain (%) | NGNE Price | NGNE Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $5.86 | +58.67% | $34.09 | -4.43% | +63.10% |
| Sep 14, 2026 | $5.97 | +61.79% | $35.21 | -1.29% | +63.08% |
| Sep 11, 2026 | $6.04 | +63.69% | $35.48 | -0.53% | +64.22% |
| Sep 10, 2026 | $6.07 | +64.50% | $36.12 | +1.26% | +63.24% |
| Sep 09, 2026 | $5.73 | +55.28% | $37.88 | +6.20% | +49.08% |
| Sep 08, 2026 | $4.34 | +17.62% | $38.13 | +6.90% | +10.72% |
| Sep 04, 2026 | $4.67 | +26.56% | $38.60 | +8.21% | +18.35% |
| Sep 03, 2026 | $4.60 | +24.66% | $37.61 | +5.44% | +19.22% |
| Sep 02, 2026 | $4.45 | +20.60% | $38.36 | +7.54% | +13.06% |
| Sep 01, 2026 | $3.83 | +3.79% | $37.87 | +6.17% | -2.38% |
| Aug 31, 2026 | $3.62 | -1.90% | $36.24 | +1.60% | -3.50% |
| Aug 28, 2026 | $3.69 | +0.00% | $36.58 | +2.55% | -2.55% |
| Aug 27, 2026 | $3.85 | +4.34% | $37.86 | +6.14% | -1.80% |
| Aug 26, 2026 | $3.80 | +2.98% | $38.41 | +7.68% | -4.70% |
| Aug 25, 2026 | $4.11 | +11.38% | $40.84 | +14.49% | -3.11% |
Page 1 of 2